Boehringer Ingelheim and Zealand Pharma's obesity drug, Survodutide, shows no increased heart risk and significant weight loss in a late-stage trial, paving the way for global regulatory approval.
Divi's Laboratories announces the establishment of new Solid Phase Peptide Synthesis (SPPS) lines to cater to increasing ...
Eli Lilly's Phase 3 trial reveals that its weight-loss pill Foundayo effectively reduces obstructive sleep apnea severity, ...
The US FDA has mandated new warnings for GLP-1 medications, including Ozempic and Zepbound, regarding a potential eye ...
AstraZeneca strengthens its vaccine pipeline by acquiring early-stage biotech firm Omniose, which specializes in developing ...
Mumbai: Drugmaker Lupin Limited ha launched raltegravir tablets in the US, following the approval of its Abbreviated New Drug ...
Zura Bio announces the failure of its experimental drug tibulizumab in a mid-stage trial for treating hidradenitis ...
ETPharma.com brings latest torrent pharmaceuticals news, views and updates from all top sources for the Indian Pharma industry.
BDR Pharmaceuticals has acquired a controlling stake in Acme Formulations' oral solid formulations division, enhancing its ...
India's NPPA caps trade margins on anti-cancer drugs to reduce costs significantly, aiming for annual savings of ₹2,500 crore ...
Alembic Pharmaceuticals has received final approval from the US FDA for its Olopatadine Hydrochloride ophthalmic solution, a ...
The FDA has approved Bayer's new blood thinner Sunharbo to prevent recurrent strokes in patients. This innovative treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results